2020 Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT) Group Chronic Malignancies Working Party (CMWP) 1st listed author Meral Beksac Journal Bone Marrow Transplant.
2020 Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Laurent Garderet Journal Biol Blood Marrow Transplant.
2020 Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Charlotte Gran Journal Br J Haematol.
2020 Hepatitis-associated aplastic anemia Group Severe Aplastic Anaemia Working Party (SAAWP) 1st listed author Alfadel Alshaibani Journal Hematol Oncol Stem Cell Ther.
2020 Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author J Loke Journal Bone Marrow Transplant.
2020 Better leukemia-free survival with allogeneic than with autologous HCT in AML patients with isolated trisomy 8: a study from the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Frédéric Baron Journal Bone Marrow Transplant.
2020 Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
2020 FLAMSA-Based Reduced-Intensity Conditioning versus Myeloablative Conditioning in Younger Patients with Relapsed/Refractory Acute Myeloid Leukemia with Active Disease at the Time of Allogeneic Stem Cell Transplantation: An Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Eduardo Rodríguez-Arbolí Journal Biol Blood Marrow Transplant.
2020 Timing of Post-Transplantation Cyclophosphamide Administration in Haploidentical Transplantation: A Comparative Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Annalisa Ruggeri Journal Biol Blood Marrow Transplant.
2020 Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Am J Hematol.
2020 Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Eolia Brissot Journal Bone Marrow Transplant.
2020 Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Monzr M Al Malki Journal Blood Adv.